News | November 04, 2009

CMS' Imaging Cuts Limit Access to Early Detection

November 4, 2009 - “We know it's less expensive to treat a disease in its early stages, yet CMS’ reimbursement policies continue to undermine the effectiveness of early diagnosis for diseases like breast cancer and heart disease," Tim Trysla, executive director of the Access to Medical Imaging Coalition (AMIC).

The Centers for Medicare and Medicaid Services (CMS) last week published final regulations that will drastically reduce physician reimbursements for medical imaging services beginning in 2010, resulting in diminished patient access to early detection tests that save lives and money, according to AMIC.

The 2010 Physician Fee Schedule released Friday by CMS will reduce payments to non-hospital practices by 48 percent for pelvis CT, by 46 percent for MRI of the chest-spine, and by 27 percent for cardiovascular-related services. Cuts to cardiology services could impact up to two-thirds of cardiovascular patients as practices are forced to shut their doors.

“As private practices close, hospital-based practices, which are largely insulated from the Medicare cuts contained in this rule, will not be able to handle the influx of patients. This rule will severely disrupt the delivery of care and patients will suffer,” said Trysla.

The Fee Schedule will reduce Medicare payments for imaging performed in non-hospital settings by reducing the values assigned to physicians’ practice expenses based on non-representative practice expense data collected through the AMA’s Physician Practice Information Survey (PPIS) and by drastically increasing the utilization assumption – the amount of time imaging equipment is assumed to operate during the hours a physician’s office or center is open – for advanced diagnostic imaging equipment from 50 percent to 90 percent over the next four years.

In a public statement, AMIC wrote: "These changes lead us down a precarious path toward large reimbursement cuts to many critical imaging services, particularly those that employ MRI and CT technology, which are hit both by the practice expense data and the utilization rate change."

It is believed these reimbursement cuts will result in reduced services, closed physician practices, long wait times and limited access for Medicare patients. Many seniors will be denied care, while many more will experience long delays or have to travel long distances to receive important diagnostic tests, which will further delay treatment. Furthermore, the cuts will increase overall patient costs as hospital-based cardiology and clinical and diagnostic services require patients to pay more out of pocket for these services than they would pay for the same care provided in physician offices.

AMIC said: "Policymakers need to recognize that reducing reimbursements for advanced imaging has a direct negative impact on the delivery of care. On top of the nearly 20 percent cut to payments for advanced imaging services in 2007, the health reform bills pending before Congress also include billions in reimbursement reductions. The unfortunate result of these policy changes will be greatly reduced access and quality of care for America's seniors, especially in rural regions of the country."

The Senate health reform legislation would move the utilization rate for CT, MR, PET and nuclear from 50 percent to 65 percent for four years, while the House bill would increase it to 75 percent.

“By pegging the utilization rate at 90 percent, CMS is adopting policy that isn’t supported by data,” Trysla said. “While CMS clearly missed the mark with this rule, we are committed to working with the agency to provide informative data regulators can use to determine an accurate and responsible utilization rate. A 90 percent utilization assumption is far from responsible public policy.”

For more information: rightscanrighttime.org

Related Content

Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Videos | Computed Tomography (CT) | July 17, 2018
An interview with Patrick Serruys, M.D., Ph.D., Imperial College London, principal investigator of the SYNTAX III Tri
Zebra Medical Vision Announces FDA 510(k) Clearance of Coronary Calcium Algorithm
Technology | Computed Tomography (CT) | July 12, 2018
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary...
IAC Awards First CT Accreditation for a Mobile Stroke Unit
News | Computed Tomography (CT) | July 09, 2018
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center...
FFR-CT may soon replace invasive angiography for coronary lesion assessment. #EuroPCR 

Anexample of a clinical case of CT-FFR, which can derive the FFR numbers for their entire coronary tree using a noninvasive CT scan.

Feature | Computed Tomography (CT) | May 29, 2018
May 29, 2018 — Results from the innovative SYNTAX III Revolution Trial [1] underline the effectiveness of evolving no
James Min Named Editor-in-Chief of Journal of Cardiovascular Computed Tomography
News | Computed Tomography (CT) | May 01, 2018
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of...
FDA Clears Siemens' Somatom go.All, go.Top CT Scanners
Technology | Computed Tomography (CT) | April 18, 2018
April 18, 2018 — The U.S.
Canon Medical Systems' Aquilion Precision CT Receives FDA Clearance
Technology | Computed Tomography (CT) | April 13, 2018
Canon Medical Systems USA Inc. this week received U.S. Food and Drug Administration (FDA) clearance for the Aquilion...
FDA Clears Siemens Somatom Edge Plus CT System
Technology | Computed Tomography (CT) | April 04, 2018
April 4, 2018 — The U.S.
Canon Medical Systems Highlights Aquilion One/Genesis CT Stroke Suite at SIR 2018
News | Computed Tomography (CT) | March 29, 2018
March 29, 2018 — The Aquilion One/Genesis Edition...
Overlay Init